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A B S T R A C T
Objective: Nonspecific health complaints associated with indoor air are common in work environments. In some
individuals, symptoms become persistent without an adequate explanation. The aim was to study factors that
associate with the health-related quality of life (HRQoL) of employees with persistent, nonspecific indoor-air-
related symptomatology.
Methods: We present baseline results of a randomized controlled trial of interventions targeted on the HRQoL of
the employees with indoor-air-associated nonspecific symptoms. The main participant-inclusion criterion was
the presence of persistent indoor-air-related multiorgan symptoms with no known pathophysiological or en-
vironment-related explanation. As a comparison for participants´ HRQoL (n=52) we used data from the gen-
eral-population Health 2011 study (BRIF8901) including information on subjects matched to the participants´
working status and age and subjects with asthma, anxiety or depressive disorder, or other chronic conditions
with work disability.
Results: The participants showed greater and a clinically significant impairment of HRQoL [M=0.83,
SE= 0.013] than individuals from the general population [M=0.95, SE=0.001, p < .001, Hedges´ g= 2.33]
and those with asthma [M=0.93, SE=0.005, p < .001, Hedges´ g=1.46], anxiety and depressive disorder
[M=0.89, SE= 0.006, p < .001, Hedges´ g= 0.73], or a chronic condition with work disability [M=0.91,
SE= 0.003, p < .001, Hedges´ g= 1.11]. Prevalent symptoms of depression, anxiety, and insomnia and poor
recovery from work were associated with a poor HRQoL.
Conclusions: Individuals with nonspecific indoor-air-associated symptoms have a poorer HRQoL than individuals
in the general population with a globally burdensome disease. Psychological distress associated with a poor
HRQoL should be considered in the making of decisions about the treatment of these patients.
Trial registration: ClinicalTrials.gov, NCT02069002
1. Introduction
Health complaints associated with indoor air are common in non-
industrial office work environments [1,2]. A study conducted in eight
European countries showed that over one-third of office workers report
complaints about indoor air quality [2] (see also [3]). For some people
indoor-air-related health complaints become persistent and are asso-
ciated with impaired quality of life and disability [4–6]. Subjects with
these complaints may attribute their symptoms to poor indoor air even
in an environment that has contaminant levels far below those tox-
icologically established to cause harmuful effects [7–9]. Indoor-air-re-
lated symptomatology may persist among some people despite im-
provements in air quality [4,10–14]. It has also been shown in clinical
settings that the condition is not always adequately explained by
medical causes [14], and attributions to other enviromental triggers are
reported to overlap with the prolonged condition [15]. The most fre-
quent health complaints related to indoor-air include respiratory
symptoms such as coughing, breathlessness, or a sore throat, as well as
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nonspecific complaints including lightheadedness, fatigue, dizziness,
and memory and gastrointestinal problems without an identifiable
medical explanation [16]. The burden of these symptoms challenges the
healthcare system. For example, one fifth of working-age women and
one tenth of working-age men in Finland report symptoms associated
with workplace indoor air, and frequent healthcare visits are related to
those symptoms. In comparison, of these same working-age women and
men, only 6 and 4% report symptoms associated with indoor air at
home. [17]
Health-related quality of life (HRQoL) has become an important
outcome measure among people with persistent health complaints. It
takes into account people's subjective evaluation of their health and it
supports the surveillance of healthcare actions [18,19]. Subjective and
persistent nonspecific health complaints are a challenge in healthcare
operations if they are not covered by standard care guidelines. This may
result in patients having unpleasant repeat experiences of seeking help
from healthcare providers [20,21] and facing degrees of uncertainty
and disappointment if the burden of their condition cannot be oper-
ationalized or treated in a standard manner [22].
Some specific stable personality traits and state characteristics have
been linked to HRQoL patterns and health outcomes. The personality
pattern of neuroticism, a pervasive tendency to experience negative
feelings such as anxiety or difficulties coping with stressors, has been
consistently linked to a reduced quality of life and to a perceived poorer
health status among individuals suffering from well-defined somatic
diseases such as asthma [23–25]. Neuroticism is also suggested to as-
sociate with increased indoor-air-related symptom reports [26], in-
dicating that it facilitates the attribution of health complaints to en-
vironmental factors [27]. Further, it has been shown in population-
based studies that both mental-health problems and chronic somatic
diseases are associated with diminished HRQoL [19,28]. A number of
studies report comorbidity of these conditions in cases of indoor-air-
associated health complaints [3,14,16]. One might therefore assume
that psychiatric symptoms are also associated with poor HRQoL in cases
of persistent indoor-air-related symptomatology. Moreover, a resource-
oriented approach to peoples´ health-promoting abilities has also been
linked to HRQoL research. An ability called sense of coherence (SOC)
has been constantly shown to protect health independently of stressful
situations [25], including among individuals with indoor-air-related
health problems [29]. However, despite the wide array of research on
factors associated with health outcomes among people with indoor-air-
related complaints, the burden of these factors remains unknown in
comparison with that of chronic diseases in the general population.
There is ongoing debate about the theoretical explanations of in-
door-air-related conditions [16,30,31], and the variety of hypotheses is
reflected in clinical practice as well [32–35]. Irrespective of the
etiology, the recognition of individual factors that affect HRQoL could
help in the targeting of healthcare operations in cases in which there is
a considerable threat of disability related to persistent indoor-air-re-
lated health complaints.
The aim of this study is to give a descriptive analysis of HRQoL data
on a group of participants in a well-defined working population, who
report indoor-air-associated nonspecific health complaints. To provide
a frame of reference, we compare participants´ HRQoL to data from a
larger representative sample of the general population who are com-
parable in terms of working status and age. Further, those in the general
population with asthma, anxiety or depressive disorder, or some other
chronic condition with work disability, were identified and compared
separately with the study participants. Another aim was to find out
whether those in the group with nonspecific indoor-air-related health
complaints experienced psychological distress and, if so, whether it was
associated with their HRQoL.
2. Materials and methods
2.1. Study design
The population for this study includes participants recruited for a
randomized clinical trial carried out in Finland by researchers at the
Finnish Institute of Occupational Health (FIOH) between the years 2014
and 2018 [36]. Volunteer participants were recruited from occupa-
tional-health-service units during 2014–2017. A physician specialized
in occupational health evaluated the participants in line with the in-
clusion criteria. The main criteria were: (i) recurrent and persistent
multiorgan symptoms including respiratory symptoms and disability
that the participants attributed to indoor air in the workplace; (ii)
symptoms had no known medical or environment-exposure-related
explanation; and (iii) the symptoms occurred in more than one indoor
environment or despite workplace adjustments (including repairs). The
cases were identified based on idiopathic environmental intolerance
criteria compatible with those proposed by Lacour et al. in 2005 [9]. A
two-week diurnal peak-expiratory-flow (PEF) measurement and a
bronchial hyperresponsiveness test [37,38] were taken to exclude un-
diagnosed or uncontrolled asthma as a cause of respiratory symptoms.
Those with self-reported physician-diagnosed asthma also filled out the
Asthma Control Test (ACT) [39] questionnaire to evaluate its control. A
detailed description of the sampling and data-collection procedure is
given in an earlier article on the study protocol (see [36]).
The15D questionnaire [40] was used to assess the primary outcome,
HRQoL. The participants' HRQoL scores were compared with available
population-based 15D reference values based on the Health 2011
Survey. The Health 2011 was a follow-up study of the comprehensive
Health 2000 Survey [41,42] that was administered to a representative
sample of the Finnish population. The reference values used here in-
cluded information on subjects with valid 15D scores (n=1792) who
were comparable with our study participants in terms of working status
and age (29 to 56 years). Of the subjects, 148 reported asthma diag-
nosed by a physician, and 167 had a depressive or anxiety disorder
diagnosed by a structured interview (the Munich version of the Com-
posite International Diagnostic Interview) [43]. In addition, 455 sub-
jects reported a chronic condition or disability or some other condition
that had lasted more than three months and affected their work ability
and daily functioning. Although two participants in our study were
under the age of 29, the population-based data were available only for
subjects aged 29 years and older.
2.2. Subjects
The initial pool of recruits for the randomized clinical trial included
75 individuals, of whom 15 did not meet all the inclusion criteria when
assessed at the FIOH, for the following reasons: asthma in poor control
or other medical reason (n=5), pregnancy (n=1), symptoms im-
proved (n=2), change in work status (n= 2), no work disability
(n= 1), other reasons (n=4). All of the 60 recruits meeting the in-
clusion criteria were given clinical health examinations, following
which eight dropped out (n=6, unmotivated or could not engage in
the study; n= 1, could not be reached; and n= 1, did not fulfill the
inclusion criteria). The final sample used in the analysis comprised 52
participants (92% women, average age 44.8 years [SD=8.9]) who
completed the recruitment questionnaire, the clinical examination, and
the study questionnaire (baseline) before the clinical trial interventions.
Table 1 presents the demographic characteristics of both the study
sample and the reference sample.
The mean onset of recurrent indoor-air-associated symptoms was
45months before the recruitment (median= 30months, range from
two to 286months). The most common self-reported physician-diag-
nosed comorbidities were allergic rhinitis (n=22, 42.3%), asthma
(n=15, 28.8%), migraine (n=15, 28.8%), atopic dermatitis (n= 15,
28.8%), depression (n=15, 28.8%) and high blood pressure (n=13,
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25.0%). No medical comorbidity was found in 10 participants (19.2%).
The current pharmacological treatments were analgesics (42.3%), an-
tihistamines (30.7%), asthma medication (28.8%) and cardiovascular
medicines (26.9%). Two participants reported taking no medication
during the four weeks before the study. Table 2 presents the clinical and
work-related characteristics of the sample.
Among the 15 participants with asthma, the ACT scores indicated
that the condition was “controlled” in nine participants (ACT ≥20
points), “not well-controlled” in five participants (ACT 16–19 points),
and “uncontrolled” in one participant (ACT ≤15 points). Spirometry
detected abnormal lung function in three cases. One patient had
bronchial hyperresponsiveness (moderate), and one participant had
abnormal PEF monitoring. On the basis of the respiratory-functioning
measurements a pulmonologist evaluated the participants with asthma
as not having uncontrolled asthma, and that poor asthma control did
not fully explain their symptoms.
2.3. Outcome variables
The primary outcome measure here is HRQoL as assessed on the
15D [40,45]. The 15D is a utility-based generic, standardized measure,
comprising the following 15 dimensions that describe physical, mental,
and social well-being: mobility, vision, hearing, breathing, sleeping,
eating, speech, excretion, usual activities, mental function, discomfort
and symptoms, depression, distress, vitality, and sexual activity. Each
dimension is graded by the respondent on a scale ranging between 1
and 5, where 1 indicates an experience of no problems at all with the
dimension and 5 indicates severe problems. The 15D can be used to
measure a vast number of health states. We used the 15D data both to
derive 15D overall scores with values from 1 (full health) to 0 (being
dead), and to obtain dimensional symptom profiles that are comparable
with the Health 2011 subsample-based reference values.
Secondary measures of personality traits, SOC, and psychiatric
symptoms and other temporary states were assessed on structured self-
report questionnaires. Personality traits were assessed on the Extra
Short Five questionnaire, which measures facets of the five-factor
model: neuroticism, extraversion, openness to experience,
Table 1
Demographic data on the study participants (n=52) and the health 2011
survey subsample reference group (n=1792).
Study sample
(n= 52)
Health 2011
(n= 1792)
N (N %) N (N %) χ2 test, p
Gender Female 48 (92.3) 993 (55,4) < 0.001
Male 4 (7.7) 799 (44.6)
Marital status Unmarried 13 (25.0) 193 (10.8) = 0.005
Married 21 (40.4) 1115 (62.2)
Cohabiting 13 (25.0) 327 (18.2)
Divorced 5 (9.6) 144 (8.0)
Widowed 13 (0.7)
Educational level Graduate 1 (1.9) 124 (6.9) < 0.001
Lower
secondary
12 (23.1) 660 (36.8)
Higher
secondary
38 (73.1) 1008 (56.3)
Unknown 1 (1.9) 0 0
Smoking Never 40 (76.9) 932 (52.4) = 0.002
Ex-smoker 8 (15.4) 422 (23.7)
Yes 4 (7.7) 425 (23.9)
High alcohol
consumptiona
7 (13) 553 (30.9) = 0.02
Mean SD Mean SD
Age 44.8 8.9 44.8 7.5
Body Mass Index 26.4 5.0 26.4 4.6
a The AUDIT alcohol consumption questionnaire (AUDIT-C)= Sum score of
the first three items of the alcohol use disorders identification test, cut-off
score > 4 refers to hazardous alcohol use in women and > 5 refers to ha-
zardous alcohol use in men [44].
Table 2
The clinical and work characteristics of the study participants (n=52).
N (N %) M (SD) Me Min - Max
Symptom duration in months a 44.9 (50.4) 30.0 [2, 286]
Years in working life 20.3 (9.6) 20.0 [2,39]
Years in current work 8.0 (8.9) 5.0 [0, 38]
Self-reported sick leave in days b 21.3 (34.0) 7.5 [0, 166]
Self-reported physician visits c 6.0 (5.6) 5.0 [0, 30]
Self-reported physician visits - indoor air d 5.2 (5.2) 4.0 [0, 30]
Work ability 6.7 (1.7) 7.0 [1,9]
Spirometry FVC% predicted 97.1 (10.3)
FEV1% predicted 94.5 (10.3)
FEV1/FVC 80.1 (5.1)
Bronchial hyperresponsiveness e Severe 0
Moderate 1 (2.0)
Mild 5 (10.2)
None 43 (87.8)
Daily diurnal PEF variability over two weeks Significant bronchial reversibility ≥3 1
Own prognosis of work ability in 2 years' time Unlikely 1 (1.9)
Not certain 18 (34.6)
Relatively certain 33 (63.5)
Self-reported comorbid disease g None 10 (19.2)
Physical f 20 (38.5)
Mental 2 (3.8)
Physical and mental 20 (38.5)
Work ability=Current work ability compared to highest work ability ever on a scale where 0= completely unable to work, and 10=work ability at one's best;
FEV1, forced expiratory volume in one second; FVC, forced vital capacity; IgE, immunoglobulin E; PEF, peak expiratory flow.
a Months
b Days during past six months
c Times during past six months
d Times during past six months because of indoor-air-associated symptoms
e n=49, examination was not done (n=1, medication in use prevented the examination; n=1 side effects related to medical examination; n=1 examination
was replaced with spirometry with bronchodilator, result was normal);
f Two of the participants also reported job-related burn-out, which is not diagnosed as a mental disease in the Finnish healthcare system, however.
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agreeableness, and conscientiousness [46]. The Extra Short Five has
proved to be a reliable and valid instrument [46,47]. SOC was assessed
on the Finnish SOC-13 scale [48,49]. The psychometric properties of
SOC-13 have proven to be good, and the instrument has been validated
both in general populations and in several clinical populations [25,50].
The Patient Health Questionnaire-9 [51] and General Anxiety Dis-
order-7 [52] were used to assess symptoms of depressive and anxiety
disorder. In addition, we used the Insomnia Severity Index to assess the
severity of insomnia [53]. Psychiatric and somatic symptoms were also
assessed on the Global Severity Index of Symptom Checklist 90 [54].
Work-related fatigue was measured on the Need for Recovery scale,
which assesses the frequency of problems in recovering from work [55].
The psychometric properties of these measurements have been shown
to be good [56–60]. We used two scales from the Quick Environmental
Exposure and Sensitivity Inventory (QEESI), Chemical Intolerance and
Life Impact, to assess multiple chemical intolerance [61]. We also used
the Penny State Worry Questionnaire [62], which concerns the ten-
dency, intensity, and uncontrollability of general worry, to measure
worrying as an independent construct of anxiety. Psychological in-
flexibility was assessed on the Acceptance and Action Questionnaire-II
[63,64]. The Cronbach's α for each of these outcome questionnaire
scales varied from 0.83 to 0.97.
HRQoL, personality traits, and SOC were assessed during the
waiting period before the clinical examination at the FIOH. Other
measurements were taken after the clinical examinations, at the same
time as the HRQoL re-evaluation (timepoint baseline).
2.4. Statistical methods
Tables 1 and 2 contain summaries of the demographic data. The
differences in the distributions of the patients' clinical characteristics
were evaluated using χ2 tests. Data were checked for outliers on a
scatter plot of the primary-outcome overall score, and one outlier was
detected. However, because the participant fullfilled the inclusion cri-
teria there was no reason to exclude the data, hence the analyses were
repeated both including and excluding the outlier. The results were
similar in both cases and thus are reported for the analyses that include
all the participants. The HRQoL scores of the participants were com-
pared with those of the reference groups by analysis of covariance.
Effect sizes were computed as Hedges´ g. The demographic and health-
related variables available in both datasets were adjusted in the models.
The distribution of the HRQoL dimensional profiles were compared
with Mann Whitney U tests. In addtition, given that women constituted
92% of the participants, statistical analyses involving HRQoL were
conducted both for women only and for both genders. Student's t-tests
were used to assess the significance of any group differences in the
mean HRQoL based on divisions according to the clinical cut-off scores
in the psychiatric measurements (no complaints – complaints). Pear-
son's r was used to measure the correlations between continuous psy-
chological measurements with no diagnosis-based or other well-defined
cut-off scores. Analyses comparing five personality patterns and SOC
were Bonferroni corrected. The level of significance was set at p < .05,
and results based on an effect size above small (r2 > 0.2) are pre-
sented. To identify the determinants of HRQoL we used multiple linear
regression (enter method) to analyze the associations between the
psychiatric and psychological measurements. So as to avoid multi-
collinearity we considered tolerances above 0.5 and variance inflator
factors under 2 acceptable, and chose the model with the significantly
best adjusted R-square. We used version 25.0 of IBM-SPSS for Windows
(SPSS Illinois, Chicago, Illinois, USA) for the statistical analyses.
3. Results
3.1. Comparison of the HRQoL scores among the study participants and the
reference groups
The participants' 15D-derived HRQoL scores were significantly dif-
ferent from those of the reference-group subjects, and from those of
subjects with asthma, depression or anxiety disorder, or with a chronic
condition affecting their work ability and daily functioning. Table 3
presents the results of the analyses of covariance. Fig. 1 shows the mean
results for the 15D, item by item, for the study participants and the
reference groups. The results for all participants and for female parti-
cipants only were robust when compared with the different reference
groups (Appendix 1). The results shown here cover all participants.
3.2. HRQoL associated with psychiatric symptoms
High levels of insomnia and high levels of depressive- or anxiety-
disorder-related symptoms among the study participants were asso-
ciated with a decreased HRQoL. A high level of chemical intolerance
was not statistically significantly related to HRQoL (Table 4).
Problems in recovery from work, a high impact of chemical intol-
erance on everyday life, and symptoms of depressive disorder were
significantly associated with a poor HRQoL. A significant model
emerged (R2=0.72, F(3, 48)= 45.62, p < .001) (Model 1, Table 5).
Having problems recovering from work was no longer significantly
associated with a poor HRQoL (p= .06) when the analyses were ad-
justed (R2=0.71, (F(3, 44)= 38.48, p < .001) (Model 2, Table 5).
Other variables presented in Fig. 2 were not significantly associated
with HRQoL when added to the model. Fig. 2 presents the correlations
between the psychological factors and HRQoL measured after the
Table 3
Comparison of the means (standard error) for health-related quality of life scores between participants during the waiting period and the reference groups, drawn
from the health 2011 survey.
Health-related quality of life
Study sample Health 2011: Reference groups
Observed mean Adjusted mean Observed mean Adjusted mean Ancova (F) df p Adjusted R2
0.83 (0.013) 0.85 (0.015) All 0.95 (0.001) 0.96 (0.014) 204.5 (1. 1809) < 0.001 0.15
0.86 (0.025) Asthma 0.93 (0.005) 0.95 (0.024) 59.40 (1, 183) < 0.001 0.27
0.86 (0.027) Depression or anxiety 0.89 (0.006) 0.92 (0.025) 14.61 (1, 199) < 0.001 0.07
0.84 (0.018) Chronic condition 0.91 (0.003) 0.93 (0.018) 58.76 (1, 491) < 0.001 0.16
Ancova=Analysis of Covariance; SE= Standard Error; Study sample= study participants (n= 52); All=All Health 2011 subjects in the reference group
(n=1772), Hedges´ g= 2.33 between the study sample and the reference group; Asthma=Health 2011 subjects with diagnosed asthma (n=146), Hedges´
g=1.46 between the study sample and the reference group; Anxiety/Depression=Health 2011 subjects with depression or anxiety disorder diagnosed in a
structured interview (n=162), Hedges´ g= 0.73 between the study sample and the reference group; Chronic condition=Health 2011 subjects with a chronic
disease diagnosed by a physician or other condition lasting more than three months affecting work ability and daily functioning (n=454), Hedges´ g= 1.11 between
the study sample and the reference group. Demographic and health-related variables adjusted in the analysis: gender, age, marital status, education, and health
related variables (smoking, alcohol consumption, and body mass index).
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health examinations.
Finally, we tested whether the prevalence of comorbid diseases
(none or physical and/or mental) was associated with the clinical
characteristics. The chi-square test results showed no significant asso-
ciation between participants with and without comorbid disease and
the time from the first symptom onset (χ2(40)= 36.90, p= .61), the
number of sick-leave days during the previous six months
(χ2(28)= 29.97, p= .37), the number of self-reported physician visits
(χ2(14)= 8.68, p= .85) or visits because of the indoor-air-related
condition (χ2(13)= 13.16, p= .44). Further, there was no significant
relationship between the time from the first symptom onset (in months)
and HRQoL (r=0.001, n=52, p= .99), and no significant associa-
tions were found between comorbid diseases and HRQoL [F
(1,38)= 0.03, p= .88] following adjustment for demographic and
health-related factors.
3.3. HRQoL associated with individual traits
Good HRQoL and high SOC had a positive, significant correlation
(r=0.49, p= .005, two-tailed), explaining 23.6% of the variation.
Following Bonferroni correction between all traits, neuroticism had a
significantly negative correlation with HRQoL (r=−0.45, n=52,
p= .005, two-tailed) explaining 20.2% of the variation. HRQoL also
correlated with other personality factors (conscientiousness r=0.31,
extraversion r=0.26, openness to experiences r=−0.10 and agree-
ableness r=0.26). However, the effect sizes remained modest and after
Bonferroni correction, none of them were statistically significant.
4. Discussion
Our results indicate that workers with persistent indoor-air-related
nonspecific symptomatology generally have lower HRQoL compared to
general-population reference groups with globally burdensome dis-
eases. We also found a wider range of subjective health complaints,
measured on dimensions of the 15D, compared to reference groups
derived from the general population with either a diagnosis of asthma,
anxiety or depressive disorder, or with a self-reported chronic disease or
other condition affecting work ability and daily functioning. Higher
levels of trait neuroticism and some types of psychological distress
(symptoms of depression, anxiety, insufficient recovery in terms of
symptoms of insomnia, and poor recovery from work) were associated
with a low HRQoL. However, HRQoL was not associated with the time
from symptom onset or with comorbid diseases.
Studies conducted among representative samples of Finnish people
imply that HRQoL remained stable in the working-age population be-
tween 2000 and 2017 [17,41]. Both age and the presence of chronic
somatic and psychiatric conditions have been shown to decrease
HRQoL [65], and psychiatric disorders have been shown to have a more
detrimental effect than other medical conditions among the under-60s
[65]. In our study, 42% of the participants reported a psychiatric dis-
order (depression and/or anxiety) previously diagnosed by a physician,
whereas 21 and 15%, respectively, reported current symptoms of
Fig. 1. Dimensions of the 15D-based health-related
quality of life for the study participants and the re-
ference groups (1= perfect functioning on the di-
mension, 5= severe disability on the dimension).
Health 2011: all subjects in the reference data
(n=1792); Health 2011: Asthma=Health 2011
subjects with diagnosed asthma (n=148); Health
2011: Anxiety or depression=Health 2011 subjects
with depression or anxiety disorder diagnosed in a
structured interview (n=167); Health 2011:
Chronic condition=Health 2011 subjects with a
chronic disease diagnosed by a physician or other
condition lasting more than three months affecting
work ability and daily functioning. The study sample
(n=52)=participants in the RCT study. a The dis-
tribution of the 15D-dimension in all subjects in
Health 2011 and Health 2011: subjects with asthma
and the Study samples is the same (Mann Whitney
U). b The distribution of the 15D-dimension in
Health 2011: chronic condition and the Study sam-
ples is the same (Mann Whitney U). c The distribu-
tion of the 15D-dimension in Health 2011: anxiety
and depression and the Study samples is the same
(Mann Whitney U).
Table 4
Means and standard deviations of the health-related quality of life (HRQoL) scores by symptom screening cut-offs after the clinical examinations.
HRQoL according to cut-off score M (SD)
Above cut-off, M (SD) Below cut-off, M (SD) t df p
PHQ n=11 0.76 (0.09) n=41 0.88 (0.06) 5.11 50 <0.001
ISI n=21 0.81 (0.09) n=31 0.88 (0.07) 2.96 50 0.005
GAD n=8 0.73 (0.09) n=44 0.87 (0.07) 4.99 50 <0.001
QEESI
Chemical intolerance n= 31 0.84 (0.07) n= 21 0.87 (0.10) 1.01 50 0.32
Life Impact n=35 0.83 (0.09) n= 17 0.89 (0.07) 2.37 50 0.02
M=Mean; SD= Standard Deviation; PHQ=Patient Health Questionnaire (Study sample M=3.33, SD=3.71). Cut-off score > 4 refers to mild to severe de-
pression; ISI= Insomnia Severity Index (M=6.31, SD 5.20). Cut-off score > 7 refers to insomnia; GAD=Generalized Anxiety Disorder (Study sample M=2.04,
SD=2.75); cut-off score > 4 refers to mild to severe anxiety; QEESI=Quick Environmental Exposure and Sensitivity Inventory, Chemical Intolerance (Study
sample M=48.42, SD=24.55); cut-off score > 40 refers to a high probability of chemical intolerance and Life Impact (Study sample M=39.13,
SD=25.58);> 24 refers to a high impact of intolerance on everyday life. N=52.
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depression or anxiety above clinical cut-off scores. It has been suggested
that these factors increase vulnerability to low HRQoL and they are
associated with persistent indoor-air-related health complaints [3,31].
Furthermore, there is evidence that they constitute a risk in terms of
adverse physical reactions related to environmental factors [66].
However, although symptoms of depression and anxiety were asso-
ciated with poor HRQoL, we did not assess their onset in our study.
Therefore, we cannot evaluate the extent to which depression and an-
xiety are a consequence of adjusting to persistent symptomatology re-
lated to indoor air, a sign of other processes, a cause of or underlying
reason for the prolonging of somatic symptoms, or all of these. How-
ever, Van Boven et al. [67] showed that unexplained physical symp-
toms are strongly associated with a depression episode in primary-care
settings. Their results support our findings indicating that signs of de-
pression are associated with somatic symptoms without an adequate
explanation, and we assume that these states affect each other and
worsen HRQoL. Thus, patients with persistent indoor-air-related
symptoms seeking primary care should be screened for symptoms of
psychological distress.
Our results are consistent with the findings reported in previous
studies on severe disability among patients with indoor-air-associated
symptoms. Several studies have shown comorbidity of somatic and
psychiatric disorders with other environment-related symptomatology
or intolerance [68,69]. However, we studied the associations of long-
term stable dispositions and psychological distress with HRQoL among
workers with no severe work disability in line with Runeson et al. [70].
They suggested that the association between neuroticism and poor
HRQoL may not merely reflect secondary reactions to indoor-air-asso-
ciated nonspecific health complaints [70]. Our results raise the question
of whether a long-term stable disposition can predispose individuals to
non-adaptive functioning in prolonged stressful situations or, in the
case of SOC, protect them from suspected environmental stress [29]. It
is noteworthy that although depression and anxiety have been linked
independently with poor HRQoL [71], the participants of our study
reported inferior HRQoL compared to groups with globally burdensome
diseases or other chronic conditions with disability. Thus, together with
current psychological distress, trait-like factors might not just worsen
HRQoL but could also make the people vulnerable to indoor air-related
health complaints.
Thus far the evidence on treatment options for prolonged indoor-
Table 5
Predictors of health-related quality of life as shown in the linear regression.
Model 1 Model 2
B 95% CI for B SE B β p B 95% CI for B SE B β p
NRF −0.003 (−0.005, 0.000) 0.001 −0.197 0.045 −0.003 (−0.005, 0.000) 0.001 −0.203 0.06
Qeesi LI −0.001 (−0.002, −0.001) 0.000 −0.332 <0.001 −0.001 (−0.002, −0.001) 0.000 −0.369 <0.001
PHQ - 9 −0.013 (0.018, −0.009) 0.002 −0.579 <0.001 −0.013 (−0.018, −0.008) 0.002 −0.577 <0.001
NRF, Need for recovery; Qeesi LI, Qeesi Life Impact; PHQ-9, Patient Health Questionnaire −9; Model 1 is unadjusted; Model 2 is adjusted for sex, age, and comorbid
diseases (dummy coded none vs one or more comorbid diseases) and symptom duration in months.
Fig. 2. Correlations (Pearson, two-tailed) and effect sizes between the HRQoL scores and scores on the PSWQ (Penn State Worry Questionnaire), NRF (Need for
Recovery), AAQ-II (Acceptance and Action Questionnaire – II), and SCL-90 GSI (Symptom Check List −90, Global Severity Index); N=52.
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air-associated nonspecific symptoms is limited. Cognitive-behavioral
psychotherapy (CBT) has shown preliminarily promising results for si-
milar conditions involving nonspecific and persistent health complaints
[72,73]. It has also been shown that problems of recovery from work as
well as depression and insomnia are associated with and even predict
higher numbers of somatic health complaints [57,74,75]. Thus, it could
be assumed from the results of this study that several comorbid states
might affect case prognosis. Recent studies have found promising evi-
dence that supporting healthy sleeping patterns through CBT also af-
fects recovery from psychiatric disorders such as depression [76–78]. It
has further been suggested that having modern health concerns such as
worrying about mold in indoor air is a predictor of somatic symptoms,
and that the physical components of HRQoL and symptoms of depres-
sion mediate this association [66]. These notions support the tailoring
of treatment for psychological distress to individual abilities to enhance
health and thereby prevent health complaints from becoming persis-
tent.
The cross-sectional design of our study allows only for speculation
as to whether the results reflect a causal relationship between psycho-
logical patterns, poor HRQoL, and persistent nonspecific indoor-air-
related symptoms. Despite the methodological challenge, however, it
has to be acknowledged that psychosocial components are inherent in
all health complaints and diseases in the context of employee dis-
comfort and health complaints in a work environment [26,30,79].
Psychosocial processes may directly constitute stressors, causing
symptoms through psychophysiological mechanisms, or they may lead
to vicious circles potentiating health complaints. Furthermore, our
analyses were based on the reports of occupational physicians on the
participants' work environment and health, as well as on participants´
self-reported data on health and the work-place environment: the psy-
chosocial climate was not included in the analysis, although there is
now some evidence that it plays a role in experiencing and reporting
indoor-air-related symptoms [80,81]. Thus, together with adopting a
more traditional focus on cause-effect relations in this context, research
should focus on people's abilities to respond to and seek help for health
complaints in which both individual and workplace characteristics play
a role. Also on the population level, individual dispositions have been
shown to associate with increasingly frequent healthcare visits among
subjects with nonspecific and recurrent respiratory health complaints
[82]. Targeting these factors in healthcare in parallel with standard
medical care would enhance good practice in terms of supporting
health-related quality of life [83].
5. Conclusion
Our findings indicate that persistent indoor-air-associated non-
specific symptoms are more closely associated with a decreased HRQoL
than asthma, depression or anxiety disorder, or even chronic conditions
with work disability. Further, both stable traits and symptoms of de-
pressive disorder or other signs of emotional distress affected the
HRQoL of employees with persistent indoor-air-associated nonspecific
symptoms. Given that self-rated health is a well-known predictor of
morbidity [84,85], healthcare actions should focus more on the pa-
tient's ability to cope with somatic conditions.
Trial status
This study has been registered at the ClinicalTrials.gov registry
(NCT02069002). Patient enrolment ended in January 2017, and the 12-
month follow-up results are expected in 2019.
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